A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

<div>Kaplan–Meier (KM) curves for patients with hepatocellular carcinoma and portal vein tumor thrombus treated by transarterial chemoembolization (TACE) + apatinib or TACE alone. Data were analyzed before the propensity score matching. (a) KM curves for the overall survival time; (b) KM curves for the time to progression.</div>

Journal of Oncology

fig2

Figure 2

Figure 2: A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus 

Figure 2 | A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus 